Drug profile · INN
triamcinolone diacetate
TRIAMCINOLONE DIACETATE
triamcinolone diacetate (TRIAMCINOLONE DIACETATE) is a glucocorticoid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — triamcinolone diacetate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 6
- Data quality
- 0.84
Quick answer
triamcinolone diacetate (TRIAMCINOLONE DIACETATE) is a glucocorticoid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is triamcinolone diacetate?
triamcinolone diacetate (TRIAMCINOLONE DIACETATE) is a glucocorticoid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for triamcinolone diacetate?
TRIAMCINOLONE DIACETATE is a marketed brand name for triamcinolone diacetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of triamcinolone diacetate?
triamcinolone diacetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.